KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 116 filers reported holding KARYOPHARM THERAPEUTICS INC in Q2 2024. The put-call ratio across all filers is 0.20 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $217 | -42.6% | 250 | 0.0% | 0.00% | – |
| Q1 2024 | $378 | +75.0% | 250 | 0.0% | 0.00% | – |
| Q4 2023 | $216 | -35.5% | 250 | 0.0% | 0.00% | – |
| Q3 2023 | $335 | -25.2% | 250 | 0.0% | 0.00% | – |
| Q2 2023 | $448 | -54.0% | 250 | 0.0% | 0.00% | – |
| Q1 2023 | $973 | +14.5% | 250 | 0.0% | 0.00% | – |
| Q4 2022 | $850 | -37.7% | 250 | 0.0% | 0.00% | -100.0% |
| Q3 2022 | $1,365 | +21.0% | 250 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $1,128 | -38.8% | 250 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $1,843 | +14.6% | 250 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $1,608 | +10.5% | 250 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $1,455 | +482.0% | 250 | -90.3% | 0.00% | -90.0% |
| Q2 2021 | $250 | -90.5% | 2,580 | +932.0% | 0.01% | +400.0% |
| Q1 2021 | $2,630 | -32.0% | 250 | 0.0% | 0.00% | -33.3% |
| Q4 2020 | $3,870 | +6.0% | 250 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $3,650 | -22.9% | 250 | 0.0% | 0.00% | -25.0% |
| Q2 2020 | $4,735 | -75.5% | 250 | -75.2% | 0.00% | -83.3% |
| Q1 2020 | $19,364 | +0.2% | 1,008 | 0.0% | 0.02% | +60.0% |
| Q4 2019 | $19,323 | +99.3% | 1,008 | 0.0% | 0.02% | +66.7% |
| Q3 2019 | $9,697 | – | 1,008 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Delphi Management Partners VIII, L.L.C. | 2,263,006 | $13,170,000 | 9.51% |
| Palo Alto Investors LP | 5,383,052 | $31,329,000 | 1.89% |
| Birchview Capital, LP | 246,000 | $1,432,000 | 0.97% |
| Lombard Odier Asset Management (Switzerland) SA | 1,517,804 | $8,834,000 | 0.55% |
| Rubric Capital Management LP | 3,375,758 | $19,647,000 | 0.55% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,401,861 | $8,159,000 | 0.30% |
| AlphaCentric Advisors LLC | 136,000 | $792,000 | 0.20% |
| Bridgefront Capital, LLC | 20,946 | $122,000 | 0.13% |
| Hennion & Walsh Asset Management, Inc. | 407,474 | $2,371,000 | 0.12% |
| Virtus ETF Advisers LLC | 44,364 | $258,000 | 0.11% |